Search
for
Sort by
Research 151–180 of 252
- Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- An Overview of the Health Benefits, Extraction Methods and Improving the Properties of Pomegranate
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Disentangling the Coronavirus Disease 2019 Health Disparities in African Americans: Biological, Environmental, and Social Factors
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies
- Alopecia in patients with COVID-19: A systematic review and meta-analysis
- COVID-19 infection is a major cause of acute telogen effluvium
- Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)
- Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2
- Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agents: An Insight
- Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Skin manifestations associated with COVID-19
- Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- The impact of individual lifestyle and status on the acquisition of COVID-19: A case—Control study
- The common regulatory pathway of COVID-19 and multiple inflammatory diseases and the molecular mechanism of cepharanthine in the treatment of COVID-19
- COVID-19 and hypopituitarism
- A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels